Medically supervised weight loss with GLP-1/GIP medications has been associated in clinical studies with reductions in body fat and visceral fat, A1C (blood sugar), LDL cholesterol, blood pressure, and liver fat beyond body weight alone
Biomarker Context and Metabolic Assessment Before Starting GLP-1 The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R variants that relate to GLP-1 and related signaling pathways
What exact medication am I receiving
Traditional diets don't work because nearly 70% of weight is genetically determined
Study: Glucagon-like peptide-1 receptor agonists and muscle mass effects
First, in composite outcomes such as MACE, differences in definition introduce heterogeneity in the analysis as seen in Supplementary Material 2